Evolution of antiretroviral prescription and response over a period of 8 years: An Italian multicentre observational prospective cohort study

Infection

Volumn 36, Issue 3, 2008, Pages 244-249

  Sighinolfi, L ^a,k   Torti, C ^b,k   Zeni, C ^b   Ghinelli, F ^a,k   Suter, F ^c,k   Maggiolo, F ^c,k   Antinori, A ^d   Antonucci, G ^d   Castelnuovo, F ^e   Ladisa, N ^f,k   Migliorino, M ^g,k   Novati, S ^h   De Luca, A ^i,i   Lo Caputo, S ^j,k   Paraninfo, G ^b   Tinelli, C ^h,k   Carosi, G ^b,k   Puoti, M ^k   Quiros Roldan, E ^k   Antonucci, F ^d   Cauda, R ⁱ   Angarano, G ^k   Saracino, A ^k   D'Arminio, A ^k   Cicconi, P ^k   Mazzotta, F ^k   Marino, N ^k   Minoli, L ^k   Maserati, R ^k   Pastore, G ^k   Quirino, T ^k   more..

^a Department of Morphology   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c OSPEDALI RIUNITI   (Italy)

^d NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^e SPEDALI CIVILI   (Italy)

^f POLICLINICO   (Italy)

^g Ospedale Civile   (Italy)

^h FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

ⁱ CATHOLIC UNIVERSITY   (Italy)

^j SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^k INMI L Spallanzani ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NON NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; VIRUS RNA;

ADULT; ARTICLE; COHORT ANALYSIS; DRUG RESPONSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ITALY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRESCRIPTION; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE; VIROLOGY;

EID: 45849086886     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-007-7227-0     Document Type: Article

References (11)

1. Palella FJ, Delaney KM, Moorman AC, loveless MO, Fuher J, Satten GA, Aschman DJ, Holmberg SD: Declining morbidity and mortality among patients with advanced immunodeficiency virus infection. N Engl J Med 1998; 338: 853-860.
2. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A, Knysz B, Dietrich M, Phillips AN, Lundgren JD, EuroSIDA Study Group Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003; 362: 22-29.
3. Sterne JAC, Hernan MA, Ledergerber BA, Tilling K, Weber R, Sendi P, Rickenbach M, Robin JM, Egger M, The Swiss Cohort Study: Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet 2005; 366: 378-384.
4. Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sorensen HT, Vaet M, Obel N: Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Int Med 2007; 146: 87-95.
5. Gulick RM, Ribaudo HJ, Shikuma CM, Lustgarten S, Squires KE, Meyer WA, Acosta EP, Schackman BR, Pilcher CD, Murphy RL, Maher WE, Witt MD, Reichman RC, Snyder S, Klingman KL, Kuritzkes DR: AIDS Clinical Trials Group Study A5095 Team Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection. N Engl J Med 2004; 350: 1850-1861.
6. Shafer RW, Smeaton LM, Robbins GK, De Gruttola V, Snyder SW, D'Aquila RT, Johnson VA, Morse GD, Nokta MA, Martinez AI, Gripshover BM, Kaul P, Haubrich R, Swingle M, McCarty SD, Vella S, Hirsch MS, Merigan TC, AIDS Clinical Trials Group 384 Team: Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection. N Engl J Med 2003; 349: 2304-2315.
7. Bartlett JA, Fath MJ, DeMasi R, Hermes A, Quinn J, Mondou E, Rosseau F: An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults. AIDS 2006; 20: 2051-2064.
8. Renaud M, Katlama C, Mallet A, Calvez V, Carcelain G, Tubiana R, Jouan M, Caumes E, Agut H, Bricaire F, Debre P, Autran B: Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen. AIDS 1999; 13: 669-676.
9. Le Moig V, Thiebaut R, Chene G, Leport C, Cailleton V, Michelet C, Fleury H, Herson S, Raffi F, APROCO Study Group: Predictors of long-term increase in CD4 (+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen. J Infect Dis 2002; 185: 471-480.
10. Suligoi B, Boros S, Camoni L, Lepore D, Ferri M, Roazzi P: Aggiornamento dei casi di AIDS notificati in Italia e delle nuove diagnosi di infezioni da HIV al 31 dicembre 2005. Not Ist Super Sanità 2006; 19: 3-23.
11. Lampe CF, Gatell JM, Stazewski S, Johnson MA, Pradier C, Gill MJ, De Lazzari E, Dauer B, Youle M, Fontas E, Krentz HB, Phillips AN: Changes over time in risk of initial virological failure of combination antiretroviral therapy. Arch Int Med 2006; 166: 521-528.